Cyclacel Pharmaceuticals Inc (CYCC)
0.41
-0.04
(-9.89%)
USD |
NASDAQ |
Nov 14, 10:31
Cyclacel Pharmaceuticals Market Cap: 0.8095M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 0.8983M |
| November 12, 2024 | 0.8094M |
| November 11, 2024 | 0.8864M |
| November 08, 2024 | 0.9496M |
| November 07, 2024 | 0.8404M |
| November 06, 2024 | 0.8195M |
| November 05, 2024 | 0.8728M |
| November 04, 2024 | 0.997M |
| November 01, 2024 | 1.238M |
| October 31, 2024 | 1.281M |
| October 30, 2024 | 1.297M |
| October 29, 2024 | 1.343M |
| October 28, 2024 | 1.382M |
| October 25, 2024 | 1.642M |
| October 24, 2024 | 1.719M |
| October 23, 2024 | 2.093M |
| October 22, 2024 | 2.823M |
| October 21, 2024 | 2.606M |
| October 18, 2024 | 2.251M |
| October 17, 2024 | 1.994M |
| October 16, 2024 | 1.954M |
| October 15, 2024 | 1.606M |
| October 14, 2024 | 1.579M |
| October 11, 2024 | 1.579M |
| October 10, 2024 | 1.570M |
| Date | Value |
|---|---|
| October 09, 2024 | 1.585M |
| October 08, 2024 | 1.757M |
| October 07, 2024 | 1.856M |
| October 04, 2024 | 1.803M |
| October 03, 2024 | 1.816M |
| October 02, 2024 | 1.836M |
| October 01, 2024 | 1.876M |
| September 30, 2024 | 1.954M |
| September 27, 2024 | 2.033M |
| September 26, 2024 | 1.974M |
| September 25, 2024 | 2.014M |
| September 24, 2024 | 2.033M |
| September 23, 2024 | 1.954M |
| September 20, 2024 | 1.935M |
| September 19, 2024 | 2.014M |
| September 18, 2024 | 2.063M |
| September 17, 2024 | 2.014M |
| September 16, 2024 | 2.033M |
| September 13, 2024 | 1.994M |
| September 12, 2024 | 2.093M |
| September 11, 2024 | 2.152M |
| September 10, 2024 | 2.093M |
| September 09, 2024 | 2.172M |
| September 06, 2024 | 2.093M |
| September 05, 2024 | 2.073M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
0.8094M
Minimum
Nov 12 2024
77.03M
Maximum
Mar 19 2021
20.23M
Average
13.13M
Median
Jan 22 2020
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 3.469M |
| Palatin Technologies Inc | 20.33M |
| iBio Inc | 19.35M |
| Theriva Biologics Inc | 1.337M |
| Oragenics Inc | 1.869M |
Market Cap Related Metrics
| PS Ratio | 6.193 |
| Price to Book Value | 0.8103 |
| Price | 0.41 |
| Earnings Yield | -4.00K% |